← FDA DRUG APPROVALS

FDA ANDA · ANDA219403

CENOBAMATE

Sponsor: ZENARA PHARMA PRIVATE LTD

APPLICATION
ANDA219403
TYPE
ANDA
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

CENOBAMATENone (Tentative Approval)
CENOBAMATE 12.5MG · TABLET
CENOBAMATENone (Tentative Approval)
CENOBAMATE 100MG · TABLET
CENOBAMATENone (Tentative Approval)
CENOBAMATE 50MG · TABLET
CENOBAMATENone (Tentative Approval)
CENOBAMATE 25MG · TABLET
CENOBAMATENone (Tentative Approval)
CENOBAMATE 200MG · TABLET

Approval history

2025-06-02UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →